Cardiac tumors screening: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| Line 6: | Line 6: | ||
==Screening== | ==Screening== | ||
*According to the USPSTF, routine screening for cardiac tumors is not recommended. | |||
*[[Transthoracic echocardiography]] (TTE) continues to be the '''method of choice''' for screening for cardiac malignancies.<ref name="pmid22447042">{{cite journal| author=Lamba G, Frishman WH| title=Cardiac and pericardial tumors. | journal=Cardiol Rev | year= 2012 | volume= 20 | issue= 5 | pages= 237-52 | pmid=22447042 | doi=10.1097/CRD.0b013e31825603e7 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=22447042 }} </ref> | |||
*Emerging technologies such as [[contrast echocardiography]] and [[three-dimensional echocardiogram]] may substantially improve the diagnostic accuracy of echocardiography.<ref name="pmid27600455">{{cite journal| author=Mankad R, Herrmann J| title=Cardiac tumors: echo assessment. | journal=Echo Res Pract | year= 2016 | volume= 3 | issue= 4 | pages= R65-R77 | pmid=27600455 | doi=10.1530/ERP-16-0035 | pmc=5292983 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=27600455 }} </ref> | |||
*The diagnostic accuracy of echocardiography is 80%. After initial diagnosis on TTE, cardiac CT/MRI are used to stage and further evaluate the tumors.<ref name="pmid29183343">{{cite journal| author=Nomoto N, Tani T, Konda T, Kim K, Kitai T, Ota M | display-authors=etal| title=Primary and metastatic cardiac tumors: echocardiographic diagnosis, treatment and prognosis in a 15-years single center study. | journal=J Cardiothorac Surg | year= 2017 | volume= 12 | issue= 1 | pages= 103 | pmid=29183343 | doi=10.1186/s13019-017-0672-7 | pmc=5704631 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=29183343 }} </ref> | |||
==References== | ==References== | ||
Revision as of 18:31, 14 May 2022
|
Cardiac tumors Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Cardiac tumors screening On the Web |
|
American Roentgen Ray Society Images of Cardiac tumors screening |
|
Risk calculators and risk factors for Cardiac tumors screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Overview
Screening
- According to the USPSTF, routine screening for cardiac tumors is not recommended.
- Transthoracic echocardiography (TTE) continues to be the method of choice for screening for cardiac malignancies.[1]
- Emerging technologies such as contrast echocardiography and three-dimensional echocardiogram may substantially improve the diagnostic accuracy of echocardiography.[2]
- The diagnostic accuracy of echocardiography is 80%. After initial diagnosis on TTE, cardiac CT/MRI are used to stage and further evaluate the tumors.[3]
References
- ↑ Lamba G, Frishman WH (2012). "Cardiac and pericardial tumors". Cardiol Rev. 20 (5): 237–52. doi:10.1097/CRD.0b013e31825603e7. PMID 22447042.
- ↑ Mankad R, Herrmann J (2016). "Cardiac tumors: echo assessment". Echo Res Pract. 3 (4): R65–R77. doi:10.1530/ERP-16-0035. PMC 5292983. PMID 27600455.
- ↑ Nomoto N, Tani T, Konda T, Kim K, Kitai T, Ota M; et al. (2017). "Primary and metastatic cardiac tumors: echocardiographic diagnosis, treatment and prognosis in a 15-years single center study". J Cardiothorac Surg. 12 (1): 103. doi:10.1186/s13019-017-0672-7. PMC 5704631. PMID 29183343.